Resources

The Full-Length PPTA Donor History Questionnaire (DHQ) and Abbreviated Questionnaire are designed to aid plasma sourcing organizations in evaluating a prospective donor’s history relative to current known safety risks, FDA regulations and recommendations, PPTA voluntary standards, and optionally, European requirements. The Full-Length PPTA DHQ is designed as a stand-alone questionnaire that may be used at each donation. It may also be used in conjunction with an abbreviated form for frequent donors.

This report presents the case for expanding the availability of blood plasma for the production of plasma-derived medicinal products for patients in all European countries, by growing local donations of plasma.

Recently introduced Ontario Bill 178 proposes a ban on compensated plasma donation. This webpage contains PPTA's response to the bill and relevant information.

Normal human immunoglobulins (IG) are used to treat patients with primary and secondary antibody deficiencies to supplement missing or malfunctioning antibodies and prevent occurrence of severe infections.